Lakefront Biotherapeutics | GLPG - Trade Creditors

Stock Price
23.40
Daily Change
-0.38 -1.60%
Monthly
-5.26%
Yearly
-5.11%
Q2 Forecast
22.89

Lakefront Biotherapeutics reported EUR95.77M in Trade Creditors for its fiscal quarter ending in March of 2026.





Trade Creditors Change Date
argenx SE USD 554.27M 297.94M Dec/2025
AstraZeneca USD 22.51B 2.78B Mar/2026
Biogen USD 358.5M 73.5M Mar/2026
Genmab DKK 6M 2M Sep/2025
Gilead Sciences USD 645M 70M Mar/2026
GlaxoSmithKline GBP 14.34B 1.05B Mar/2026
GRIFOLS EUR 841M 37.68M Dec/2025
Hikma Pharmaceutical USD 715M 104M Dec/2025
Incyte USD 228.62M 1.41B Mar/2026
Merck EUR 2.11B 182M Dec/2025
Neurocrine Biosciences USD 691.3M 145.8M Mar/2026
Novartis USD 4.32B 134M Mar/2026
Roche Holding CHF 5.78B 1.27B Dec/2025
Sanofi EUR 22.71B 219M Mar/2026
UCB EUR 4.04B 755M Dec/2025
Vertex Pharmaceuticals USD 3.47B 40.6M Mar/2026